Avego Healthcare Capital Mergers and Acquisitions Summary

Private Equity Profile

Avego Healthcare Capital’s most common sector for investment is life science (100%). The Firm’s most common investment types include buyout (lbo, mbo, mbi) (34%) and growth capital (34%). In total, Avego Healthcare Capital has invested in 2 US states.

Join Mergr to view Avego Healthcare Capital’s full profile and discover more small private equity firms just like it.

M&A Summary

  • M&A Total Activity3
    • M&A Buy Activity3
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 1

Avego Healthcare Capital

,
www.avegohc.com


Investment Criteria

Sectors of Interest: Healthcare Services, Life Science, Medical Products, Packaging

Target Transaction Types: Buyout (LBO, MBO, MBI), Growth Capital, Secondary Buyout, Venture

Geographic Preferences: East US, Midwest US, South US, West US

Transaction Criteria Min Max
Target Revenue - -
Target EBITDA - -
Investment Size - -
Enterprise Value - -

M&A Summary

Buy vs Sell

Year ≤ '15 '16 '17 '18 '19 '20 T
Buy (0.4/yr) # 1 - 1 1 - - 3
Sell (0.0/yr) # - - - - - - 0
  3

Most Recent M&A

Company Date Value Type
Meridien Research Group 2018-04-16 - Secondary Buyout
Tampa, Florida · www.meridienresearch.net
Saol Therapeutics 2017-01-02 - Buyout (LBO, MBO, MBI)
Roswell, Georgia · www.saolrx.com
Sebela Pharmaceuticals, Inc. 2013-08-26 - Growth Capital
Roswell, Georgia · www.sebelapharma.com
View All >>

Portfolio M&A

Company Acquired Add-On/Sale Date #
Saol Therapeutics 2017-01-02 Aptevo Therapeutics, Inc. - Hyperimmune Commercial Products 2017-08-31 1
Roswell, Georgia · www.saolrx.com Seattle, Washington

M&A by Sector

Sector Current # Value All-time # Value
Life Science 3 (100%) - 3 (100%) -
Total 3 - 3 -

Acquisitions By Geo

State/Country Current # Value All-time # Value
United States 3 (100%) - 3 (100%) -
  Georgia 2 (67%) - 2 (67%) -
  Florida 1 (33%) - 1 (33%) -
Total 3 - 3 -

Acquisitions by Deal Type

Type Current # Value All-time # Value
Buyout (LBO, MBO, MBI) 1 (33%) - 1 (33%) -
Growth Capital 1 (33%) - 1 (33%) -
Secondary Buyout 1 (33%) - 1 (33%) -
Total 3 - 3 -

M&A Connections

Deals %
Acquired from
PE Firm(s)
100%
2 100%

Investor Summary

Size

Small

Established

2015

Specialist/Generalist

Specialist

Leadership

Bala Venkataraman

Partner

Thomas Vandervort

Partner

James Flexner

Partner

Reid Petersen

Vice President

Kevin McNeill

Vice President

 Subscribe to unlock this and 147,978
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.8K Private Equity Firms
  • 135K M&A Transactions
  • 144K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.0K M&A Advisors
    (Investment Banks and Law Firms)
  • 37K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Mergr

Product

Company

Legal